China’s Fosun owned Gland Pharma Ltd initial public offering (IPO) closed successfully on Wednesday, witnessing a subscription of 2.05 times, riding on demand from institutional investors.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
